Catalyst Wire Dossier Catalyst Wire Dossier

Olmesartan medoxomil-hydrochlorothiazide

olmesartan medoxomil-hydrochlorothiazide · Novadoz Pharmaceuticals LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Olmesartan medoxomil-hydrochlorothiazide, covering 2010-09-29 to 2025-09-26. Get the full timeline:

Most recent: FDA Approved: OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE — Original Application (Novadoz Pharmaceuticals LLC)

See pricing